Clinical Trial Update: Diltiazem in Jervell and Lange-Nielsen Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating diltiazem for Jervell and Lange-Nielsen syndrome has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Jervell and Lange-nielsen Syndrome

Drugs mentioned

• Diltiazem (diltiazem)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Jervell and Lange Nielsen Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2025-10-14